<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>50604724623672</udiDi>
    <basicUdiDi>B-50604724623672</basicUdiDi>
    <tradeName>Factor h</tradeName>
    <deviceName>Factor h</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6118</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:21:23.378Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724623504</udiDi>
    <basicUdiDi>B-50604724623504</basicUdiDi>
    <tradeName>Factor enz15</tradeName>
    <deviceName>Factor enz15</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6117</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:21:18.707Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724623436</udiDi>
    <basicUdiDi>B-50604724623436</basicUdiDi>
    <tradeName>Factor enx</tradeName>
    <deviceName>Factor enx</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6116</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:21:18.283Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724623368</udiDi>
    <basicUdiDi>B-50604724623368</basicUdiDi>
    <tradeName>Factor eh</tradeName>
    <deviceName>Factor eh</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6115</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:21:17.738Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724623290</udiDi>
    <basicUdiDi>B-50604724623290</basicUdiDi>
    <tradeName>E Complex eh, enx, enz15</tradeName>
    <deviceName>E Complex eh, enx, enz15</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6114</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:21:16.420Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724623122</udiDi>
    <basicUdiDi>B-50604724623122</basicUdiDi>
    <tradeName>Factor d</tradeName>
    <deviceName>Factor d</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6113</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:21:13.279Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724623054</udiDi>
    <basicUdiDi>B-50604724623054</basicUdiDi>
    <tradeName>Factor c</tradeName>
    <deviceName>Factor c</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6112</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:21:13.219Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724622996</udiDi>
    <basicUdiDi>B-50604724622996</basicUdiDi>
    <tradeName>Factor b</tradeName>
    <deviceName>Factor b</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6111</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:21:10.711Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724622828</udiDi>
    <basicUdiDi>B-50604724622828</basicUdiDi>
    <tradeName>Factor a</tradeName>
    <deviceName>Factor a</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6110</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:21:09.907Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724622750</udiDi>
    <basicUdiDi>B-50604724622750</basicUdiDi>
    <tradeName>Factor 55</tradeName>
    <deviceName>Factor 55</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6041</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:21:06.225Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724622682</udiDi>
    <basicUdiDi>B-50604724622682</basicUdiDi>
    <tradeName>Vi Factor</tradeName>
    <deviceName>Vi Factor</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6040</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:21:06.164Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724622514</udiDi>
    <basicUdiDi>B-50604724622514</basicUdiDi>
    <tradeName>Group S Factor 41</tradeName>
    <deviceName>Group S Factor 41</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6039</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:21:04.936Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724622446</udiDi>
    <basicUdiDi>B-50604724622446</basicUdiDi>
    <tradeName>Group R Factor 40</tradeName>
    <deviceName>Group R Factor 40</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6038</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:21:03.642Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724622378</udiDi>
    <basicUdiDi>B-50604724622378</basicUdiDi>
    <tradeName>Group Q Factor 39</tradeName>
    <deviceName>Group Q Factor 39</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6037</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:21:00.793Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724622200</udiDi>
    <basicUdiDi>B-50604724622200</basicUdiDi>
    <tradeName>Group P Factor 38</tradeName>
    <deviceName>Group P Factor 38</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6036</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:20:59.617Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724622132</udiDi>
    <basicUdiDi>B-50604724622132</basicUdiDi>
    <tradeName>Group O Factor 35</tradeName>
    <deviceName>Group O Factor 35</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6035</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:20:59.237Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724622064</udiDi>
    <basicUdiDi>B-50604724622064</basicUdiDi>
    <tradeName>Group N Factor 30</tradeName>
    <deviceName>Group N Factor 30</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6034</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:20:58.648Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724621906</udiDi>
    <basicUdiDi>B-50604724621906</basicUdiDi>
    <tradeName>Group M Factor 28</tradeName>
    <deviceName>Group M Factor 28</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6033</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:20:53.474Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724621838</udiDi>
    <basicUdiDi>B-50604724621838</basicUdiDi>
    <tradeName>Group L Factor 21</tradeName>
    <deviceName>Group L Factor 21</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6032</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:20:52.851Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724621760</udiDi>
    <basicUdiDi>B-50604724621760</basicUdiDi>
    <tradeName>Group K Factor 18</tradeName>
    <deviceName>Group K Factor 18</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6031</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:20:51.921Z</lastUpdated>
  </row>
</eudamedExport>